Bringing AI Precision to Angiography

Designed to assist clinicians in evaluating angiographic images, including features associated with stenosis, physiology, and microvascular function.

AngioInsight software

CAUTION: The AngioAI+™ platform is an investigational device. Limited by Federal (or United States) law to investigational use.

Leaving the Crowded FFR Field Behind…AngioInsight has Advanced Cardiology AI

Microvascular dysfunction is increasingly recognized as a contributor to chest pain—particularly among women. AngioInsight is designed to support clinicians with additional image-based information.

Schedule a Meeting

Intelligent Software for Angiography

AI-driven solution developed to provide AI-based analysis of of angiographic video shortly after image acquisition​
Learn More
Coronary Microvascular Disease (CMD) and Coronary Artery Disease (CAD) measurements in one simple workflow​
Learn More
Designed for use with standard angiography without requiring additional hardware
Learn More
Automated and streamlined workflow ​-NO skilled superusers required
Learn More

Understanding Coronary and Microvascular Disease

Coronary Microvascular Disease (CMD)

  • Diagnostic Challenges: CMD is difficult to identify due to nonspecific symptoms such as chest pain, shortness of breath, and fatigue, which overlap with other cardiac conditions.
  • Limitations of Angiography: This method often fails to detect abnormalities in small blood vessels.
  • Underdiagnosis and Misdiagnosis: CMD is frequently underdiagnosed or misdiagnosed, leading to treatment delays, particularly in women.
Women’s Heart Health Initiative

Coronary Artery Disease (CAD)

  • Leading Cause of Death: CAD remains the #1 killer.
  • Prevalence: Over 20.5 million U.S. adults suffer from CAD, making it the most common form of heart disease.1
  • Diagnostic Inaccuracy:
    • Over 2.2 million CAD patients undergo angiography annually to evaluate blood vessel blockages.2
    • Nearly 2 million of these patients receive a diagnosis based on subjective physician visual assessments of angiograms.3
Microvascular Disease (MVD)
Microvascular Disease (MVD)

Myth vs Fact:

MYTH

Angiography tells the whole story.

Fact

Angiography primarily visualizes epicardial vessels; microvascular dysfunction may exist even when angiographic findings appear mild or normal.

Reference: Camici PG, Crea F. Coronary microvascular dysfunction. New England Journal of Medicine. 2007.

Myth

Persistent chest pain without blockages is non-cardiac.

Fact

CMD can cause real ischemic symptoms despite the absence of obstructive disease, affecting quality of life and long-term risk.

Reference: Taqueti VR, Di Carli MF. Coronary microvascular disease pathogenic mechanisms and therapeutic options. Journal of the American College of Cardiology. 2018.

Myth

Coronary Microvascular Disease is rare.

Fact

CMD is increasingly recognized as a common contributor to angina and ischemia, yet remains underdiagnosed in routine workflows.

Reference: Bairey Merz CN, et al. Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies. Circulation/. 2017.

 

Myth

Heart disease in women always presents with blocked arteries.

Fact

CMD is more prevalent in women and often occurs without obstructive coronary artery disease, contributing to underdiagnosis and delayed care.

Reference: Shaw LJ, et al. Women and ischemic heart disease: evolving knowledge. Journal of the American College of Cardiology. 2009.

Myth

If coronary arteries look “normal,” the patient doesn’t have heart disease.

Fact

CMD affects small vessels invisible on routine angiography and can drive ischemia, symptoms, and adverse outcomes.

Reference: Murthy VL, et al. Coronary vascular dysfunction and prognosis in patients with chronic chest pain. Journal of the American College of Cardiology. 2014.